Eli Lilly (LLY) Director Ralph Alvarez Receives 10.826-Share Award

What Happened Ralph Alvarez, a director of Eli Lilly & Co. (LLY), received an award of 10.826 shares on 2026-07-20. The reported per-share value was $1,146.90, for a total reported value of $12,417. This was an award/grant (code A) and not an open-market purchase or sale.

Key Details

• Transaction date: 2026-07-20; reported value: $1,146.90 per share; total reported value: $12,417.
• Shares acquired: 10.826 (reported as stock units).
• Shares owned after transaction: not disclosed in this filing.
• Footnote F1: Alvarez elected to defer these shares in lieu of cash under the Lilly Directors' Deferral Plan; the units will be settled in common stock following his separation from service.
• Footnote F2: Alvarez disclaims beneficial ownership of the securities except to the extent of his pecuniary interest.
• Filing date: 2026-07-21 (appears timely based on the report period).

Context This was an awarded/deferred grant under a directors' deferral plan, not a purchase or a sale. Deferred stock-unit awards are commonly used for director compensation and are typically settled in shares at separation; they do not by themselves indicate a change in the director's market view.